Classys Inc
KOSDAQ:214150
Gross Margin
Classys Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
KR |
C
|
Classys Inc
KOSDAQ:214150
|
4.2T KRW |
79%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
226B USD |
56%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.4B USD |
67%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
151.5B USD |
69%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
141.5B USD |
64%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
108.6B USD |
66%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
59.9B USD |
45%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
53.2B EUR |
38%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
44.9B USD |
79%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
266.3B CNY |
64%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.7B USD |
61%
|
Classys Inc
Glance View
Classys Inc., a South Korean powerhouse in the world of aesthetic medical devices, has carved a niche for itself by capitalizing on the soaring demand for non-invasive beauty treatments. Founded in 2007, the company quickly identified a growing market shift towards minimally invasive procedures, and leveraged its technological prowess to develop cutting-edge solutions. Focusing on continuous innovation, Classys has developed a robust portfolio of high-quality products, including popular devices like Clatuu Alpha for fat reduction and Ultraformer for skin lifting. These devices cater to clinics and professionals seeking reliable, effective solutions for their clients' aesthetic needs. The company strategically invests in research and development to stay ahead in this highly competitive sector, continually upgrading its offerings to suit market trends. Operating in over 60 countries, Classys has effectively harnessed the power of global distribution networks and strategic partnerships to bolster its market presence. The company's business model primarily revolves around direct sales and distribution agreements, generating revenue by selling advanced aesthetic devices to medical professionals, clinics, and distributors worldwide. By providing training and after-sales services, Classys ensures customer satisfaction and fosters long-term relationships, which are crucial for repeat business. Additionally, its strong emphasis on compliance with international safety standards and certifications has bolstered its reputation, enabling the company to expand its footprint in emerging markets. This strategic approach has allowed Classys to maintain steady growth in an industry where technological advancements and consumer preferences are in constant flux.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Classys Inc's most recent financial statements, the company has Gross Margin of 78.7%.